PuSH - Publication Server of Helmholtz Zentrum München

Journal browsing

11 Records found.
Zum Exportieren der Ergebnisse bitte einloggen.
▮◀ ◀◀ ▶▶ ▶▮
Lay all publications on this page into basket
1.
Buchner, J.A.* et al.: Radiomics-based prediction of local control in patients with brain metastases following postoperative stereotactic radiotherapy. Neuro. Oncol. 26, 1638-1650 (2024)
2.
Kurz, S.C.* et al.: Towards more Diversity in Neuro-oncology Leadership-the DivINe Initiative. Neuro. Oncol. 25, 2302-2304 (2023)
3.
Kebir, S.* et al.: Gender disparity regarding work-life balance satisfaction among German neuro-oncologists: A YoungNOA survey. Neuro. Oncol. 24, 1609-1611 (2022)
4.
Volmar, M.N.M.* et al.: Cannabidiol converts NFκB into a tumor suppressor in glioblastoma with defined antioxidative properties. Neuro. Oncol. 23, 1898-1910 (2021)
5.
Bernhardt, D. et al.: Neuro-oncology managment during the COVID-19 pandemic with a focus on WHO grade III and IV gliomas. Neuro. Oncol. 22, 928-935 (2020)
6.
Bernhardt, D. & Combs, S.E.: Reply to: Call of duty: Neuro-oncology outpatient management during the COVID-19 pandemic in Milan, ITALY. Neuro. Oncol. 22:1893 (2020)
7.
Sbiera, S.* et al.: Driver mutations in USP8 wild-type Cushing's disease. Neuro. Oncol. 21, 1273-1283 (2019)
8.
Volmar, M.* et al.: RelA-activity is essential for cannabidiol-mediated cytotoxicity in an identified subset of glioblastoma. Neuro. Oncol. 21, 70-71 (2019)
9.
Andor, N.* et al.: Clonal expansions and evolving subpopulations in glioblastoma multiforme. Neuro. Oncol. 15, 136-137 (2013)
10.
Schäfer, A.* et al.: Aldehyde dehydrogenase 1A1 - a new mediator of resistance to temozolomide in glioblastoma. Neuro. Oncol. 14, 1452-1464 (2012)
11.
Rasper, M.* et al.: Aldehyde dehydrogenase 1 positive glioblastoma cells show brain tumor stem cell capacity. Neuro. Oncol. 12, 1024-1033 (2010)
▮◀ ◀◀ ▶▶ ▶▮